Purchase Order 36C25620P0044
Award Date
10/1/19
Potential Completion Date
12/30/24
Potential Value
$889K
Funding Federal Agency
Veterans Integrated Service Network 17
Contracting Federal Agency
Veterans Integrated Service Network 16
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price definitive contract awarded by the Veterans Integrated Service Network 17 of the Department of Veterans Affairs to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for $1,010,000.00 and has a period of performance through September 30, 2028. The contract is for genetics testing services, including clinical genetic testing, germline genetic testing utilizing whole genome sequencing, custom gene...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a provider of genomic testing services and COVID-19 testing kits and services to U.S. federal government agencies. The contract is for germline genetic testing with a potential value of $150,000.00 and is a Firm Fixed Price BPA Call order. Fulgent Therapeutics holds a separate $950,000.00 Blanket Purchase Agreement from...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for germline genetic testing services. The contract has a ceiling value of $95,817.89 and a period of performance through September 30, 2018. It was awarded as a total small business set-aside. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits and services to various federal agencies, including the VA,...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for $201,500 to provide clinical genetic testing services for chronic kidney disease. The contract has a performance period through January 17, 2024. Fulgent Diagnostics is a division of Fulgent Genetics, Inc., which specializes in genetic and genomic testing services for the federal government, including the VA,...
The Department of Veterans Affairs Veterans Health Administration awarded Fulgent Therapeutics LLC a $3.2 million firm fixed price delivery order against its Medical Laboratory Testing and Analysis Services GSA Schedule contract. Fulgent Therapeutics, doing business as Fulgent Diagnostics and a division of Fulgent Genetics, will provide COVID-19 cost per test services to VHA's Veterans Integrated Service Network 21 through December 2020. The contract supports VHA's coronavirus disease testing...
This is a $6,489,759.80 firm fixed price Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc., for germline genetic testing services. The contract has a 3-year term through September 2025 and is not set-aside. The contract will provide national access to specialized comprehensive reference laboratory testing services, including mandatory...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for SARS-COV-2 genomic sequencing services. The firm fixed price contract has a potential value of $40,517,395.00 and a completion date of March 10, 2022. Fulgent Diagnostics is a division of Fulgent Genetics, Inc. and has provided genetic and genomic testing services to various federal agencies,...
This is a federal contract award from the Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The $2,300,000 firm fixed-price delivery order is for germline pharmacogenomic molecular testing services, with a period of performance through September 30, 2025. The contract is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the VA Strategic...
This federal contract award, valued at $247,000.00, was issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Fulgent Genetics, Inc. for genetic testing services to support the VA Portland Health Care System. The contract is a firm-fixed-price purchase order with a period of performance through July 31, 2029. Fulgent Genetics, a for-profit organization specializing in advanced genetic testing and genomic services, has secured multiple...
This is a definitive contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center Frederick to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $146,265,755.00 contract is for the delivery of COVID-19 and flu test kits and swabs, with a completion date of February 27, 2023. The contract is a firm fixed-price arrangement with no set-aside designation. Cepheid is a long-standing federal contractor, having received multiple prime contracts,...